Treatment of multiply relapsed wilms tumor with vincristine, irinotecan, temozolomide and bevacizumab

Publisher： John Wiley & Sons Inc

E-ISSN： 1545-5017|61|4|756-759

ISSN： 1545-5009

Source： PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol.61, Iss.4, 2014-04, pp. : 756-759

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bevacizumab plus Irinotecan-Based Regimens in the Treatment of Metastatic Colorectal Cancer

By  

Oncology, Vol. 79, Iss. 1-2, 2010-11 ,pp. : 118-128

Karger

Access to resources Recommend Favorite

Treatment of relapsed Wilms tumour (WT) patients: Experience with topotecan. A report from the SIOP Renal Tumour Study Group (RTSG)

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 4, 2015-04 ,pp. : 598-602

John Wiley & Sons Inc

Access to resources Recommend Favorite

Combination of Cisplatin, Ifosfamide, and Irinotecan with rhG-CSF Support for the Treatment of Refractory or Relapsed Small-Cell Lung Cancer

By  

Oncology, Vol. 59, Iss. 2, 2000-08 ,pp. : 105-109

Karger

Access to resources Recommend Favorite

Wilms tumor and breast cancer

By  

CANCER, Vol. 121, Iss. 12, 2015-06 ,pp. : 2099-2099

John Wiley & Sons Inc

Access to resources Recommend Favorite

Wilms’ Tumor in Children: An Overview

By  

Nephron Clin Pract, Vol. 108, Iss. 2, 2008-01 ,pp. : c83-c90

Karger

Access to resources Recommend Favorite